PMID- 36822665
OWN - NLM
STAT- MEDLINE
DCOM- 20230227
LR  - 20230227
IS  - 2052-4897 (Electronic)
IS  - 2052-4897 (Linking)
VI  - 11
IP  - 1
DP  - 2023 Feb
TI  - Effectiveness of synchronous teleconsultation for patients with type 2 diabetes 
      mellitus: a systematic review and meta-analysis.
LID - 10.1136/bmjdrc-2022-003180 [doi]
LID - e003180
AB  - The popularity of teleconsultation during the COVID-19 pandemic enabled increased 
      accessibility for individuals with type 2 diabetes mellitus (T2DM). However, 
      previous studies did not distinguish between synchronous and asynchronous 
      teleconsultation. We evaluated the effectiveness of synchronous teleconsultation 
      for patients with T2DM. We searched Medline, Embase, Cochrane Central Register of 
      Controlled Trials, Cochrane Library and Cochrane Database of Systematic Reviews, 
      ClinicalTrials.gov, and the WHO International Clinical Trials Registry Platform 
      databases from inception to July 2021. All included studies were randomized 
      controlled trials of synchronous teleconsultation for adults with T2DM compared 
      with usual care. Reviewers independently extracted data and used the Cochrane 
      tool to evaluate risk of bias. Meta-analyses were conducted using random-effects 
      models. A pooled mean difference for both HbA1c (%) and body mass index (BMI) 
      (kg/m(2)), systolic blood pressure (SBP) (mm Hg), diastolic blood pressure (DBP) 
      (mm Hg), and low density lipoprotein cholesterol (LDL-cholesterol) (mg/dL) were 
      calculated. Patient-reported outcomes, such as depression, medication adherence, 
      and quality of life, were also assessed. A total of 9807 abstracts were 
      identified and 27 trials were included. Synchronous teleconsultation 
      significantly resulted in greater decrease in HbA1c compared with usual care 
      group (n=8746, 0.35, 95% CI 0.20 to 0.49, I(2)=73%, p<0.001). No significant 
      effects on BMI (n=699, 0.08 kg/m(2), 95% CI -0.54 to 0.69), SBP (n=5512, 1.32 mm 
      Hg, 95% CI -0.09 to 2.73), DBP (n=2898, 0.17 mm Hg, 95% CI -1.18 to 1.52), or 
      LDL-cholesterol (n=5276, 3.21 mg/dL, 95% CI -1.75 to 8.17) were found. The effect 
      of teleconsultation in improving patient-reported outcomes was uncertain. Thus, 
      synchronous teleconsultation could be an alternative to usual care. Systematic 
      review registration is PROSPERO CRD42021267019.
CI  - (c) Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No 
      commercial re-use. See rights and permissions. Published by BMJ.
FAU - Zhang, Jianxin
AU  - Zhang J
AUID- ORCID: 0000-0002-3790-0622
AD  - General Practice Department, Peking University First Hospital, Beijing, China.
FAU - Ji, Xinxin
AU  - Ji X
AUID- ORCID: 0000-0003-1832-7012
AD  - Family Medicine Center, The First Affiliated Hospital of Shantou University 
      Medical College, Shantou, Guangdong, China.
FAU - Xie, Jieying
AU  - Xie J
AD  - Emergency department, Nanfang Hospital Southern Medical University, Guangzhou, 
      Guangdong, China.
FAU - Lin, Kai
AU  - Lin K
AD  - Family Medicine Center, The First Affiliated Hospital of Shantou University 
      Medical College, Shantou, Guangdong, China.
FAU - Yao, Mi
AU  - Yao M
AD  - General Practice Department, Peking University First Hospital, Beijing, China.
FAU - Chi, Chunhua
AU  - Chi C
AD  - General Practice Department, Peking University First Hospital, Beijing, China 
      0061000063@bjmu.edu.cn.
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Research Support, Non-U.S. Gov't
PT  - Systematic Review
PL  - England
TA  - BMJ Open Diabetes Res Care
JT  - BMJ open diabetes research & care
JID - 101641391
RN  - 0 (Glycated Hemoglobin)
RN  - 0 (Cholesterol, LDL)
SB  - IM
MH  - Adult
MH  - Humans
MH  - *Diabetes Mellitus, Type 2/epidemiology/therapy
MH  - *Remote Consultation
MH  - Quality of Life
MH  - Glycated Hemoglobin
MH  - Pandemics
MH  - *COVID-19
MH  - Cholesterol, LDL
MH  - Randomized Controlled Trials as Topic
PMC - PMC9950897
OTO - NOTNLM
OT  - Dietetics
OT  - Meta-Analysis
OT  - Telemedicine
COIS- Competing interests: None declared.
EDAT- 2023/02/24 06:00
MHDA- 2023/03/03 06:00
PMCR- 2023/02/23
CRDT- 2023/02/23 20:53
PHST- 2022/10/13 00:00 [received]
PHST- 2023/01/21 00:00 [accepted]
PHST- 2023/02/23 20:53 [entrez]
PHST- 2023/02/24 06:00 [pubmed]
PHST- 2023/03/03 06:00 [medline]
PHST- 2023/02/23 00:00 [pmc-release]
AID - 11/1/e003180 [pii]
AID - bmjdrc-2022-003180 [pii]
AID - 10.1136/bmjdrc-2022-003180 [doi]
PST - ppublish
SO  - BMJ Open Diabetes Res Care. 2023 Feb;11(1):e003180. doi: 
      10.1136/bmjdrc-2022-003180.